Biomarkers & CDx

March 23 – 24, 2027 | Sheraton Boston Hotel, Boston, MA

Programme Summary

The Biomarkers & CDx programme covers the key areas in the implementation of precision medicine in translational and clinical development. Key themes cover translational biomarkers, liquid biopsies, biomarker analysis technologies, clinical trials, and diagnostic regulations, with speakers and exhibitors providing insights into how these are contributing to the development of tailored medicine.  

Across the two event days, the programme delves into the key questions troubling the field with discussion sessions exploring the relationships between genomic data and biomarker identification, computational tools for biomarker analysis, and regulatory hurdles to allow delegates to leave with an understanding of how the programme fits into the wider landscape of precision medicine  

Biomarkers CDx Speaker

2026 Highlights

Engaging Thought Leadership
Experience a variety of interactive discussions, thought leadership debated, & collaborative roundtables, with insights from industry leaders on key developments and pain points in the advancement of multi-omics.

Global Technology Showcase
An international exhibition showcasing cutting-edge technologies & services from premier providers in the scientific field.

Networking Emphasis
Unparalleled networking opportunities, including personalised 1-2-1 meetings, a vibrant drinks reception, and informal gatherings to foster meaningful connections.

PM East Circle Photo 1
PM East Circle Photo 2
1000

leading pharma, biotech, regulatory & academic delegates

700
pre-arranged 1-2-1 meetings, facilitating business growth
50
hours of presentations, discussions & interactive content
12
hours of networking breaks, including fireside chats & refreshments

Agenda at a Glance

Day One

  • Biomarkers in Translational & Clinical Development 

  • Liquid Biopsy ctDNA & MRD for Precision Medicine 

  • Tools & Technologies for Biomarker Analysis 

Day Two

  • Biomarkers for Clinical Trials & Personalized Patient Treatment

  • Companion Diagnostics & Regulations 

NGO US 26 - Programme Image 4

Spatial Multi-Omics 2026 Agenda at a Glance

DAY ONE 

Track 2: Emerging Multi-Omics Platforms and Applications: Genomics & Transcriptomics 
Track 3: Spatial Biology for Therapeutic Discovery & Development (Oncology & Immunology) 

DAY TWO 

Track 1: Emerging Multi-Omics Platforms and Applications: Proteomics, Epigenomics & Metabolomics 
Track 2: Spatial Biology for Therapeutic Discovery & Development
Pre Med + LSX Combined Logo

Unlock the Latest News and Insights

Sign-up for our regular LifeScienceXchange newsletter to keep up to date with all things Precision Medicine, direct to your inbox.

Pre Med Newsletter Icon-1

Secure Your Place

Join leading voices in Biomarkers & CDx for two days of insight, networking and dealmaking. Places are limited.

Get in Front of the Right Audience

Connect with decision-makers across Biomarkers & CDx and elevate your brand at Precision Medicine East

Decision 1

Sentence describing Decision 1

Decision 2

Sentence describing Decision 2